Neratinib | Health Canada Patents | Expiry | Expiration | Dates | PharmaCompass.com

Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
CDMO Prospector
- Demo Dashboard
Drugs in Dev.
News
Blog
Market Place
Login

Neratinib
Health Canada Patents

Veranova: A CDMO that manages complexity with confidence.

Contact Supplier

Nuray is an expert in the synthesis of Niche novel APIs, the first to launch Generics, NCEs, Advanced Intermediates // USFDA certified.

Contact Supplier

pharmacompass-1-m-2025-08-25

Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.

Contact Supplier

SPI Pharma has been solving formulation challenges using superior functional materials.

Contact Supplier

pharmacompass-2-m-2025-08-25

Neratinib

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

14 API Suppliers, 3 USDMF, 1 EU WC, 1 KDMF, 3 NDC API, 8 Listed Suppliers, $ API Reference Price

14 API Suppliers
3 USDMF
1 EU WC
1 KDMF
3 NDC API
8 Listed Suppliers
$ API Reference Price

DEVELOPMENTS

93 Drugs in Development

93 Drugs in Development

INTERMEDIATES

2 Intermediate Suppliers

2 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

3 FDF Dossiers, 2 FDA Orange Book, 1 South Africa

3 FDF Dossiers
2 FDA Orange Book
1 South Africa

RELATED EXCIPIENT COMPANIES

1 Rochem International Inc, 14 SPI Pharma, 3 DKSH, 5 Boai NKY Pharmaceuticals Ltd, 3 Gangwal Healthcare, 1 Pfanstiehl, 3 Actylis, 1 Aeon Procare, 1 Alcedo Pharmachem, 4 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 2 Ashland, 23 BASF, 5 Corel Pharma Chem, 2 DFE Pharma, 1 Esteem Industries, 1 Finar, 9 Gangwal Chemicals, 2 Ideal Cures, 1 Ingredion Pharma Solutions, 5 Kerry, 1 Keval Exports, 11 Microlex e.U, 2 Nitika Pharmaceutical Specialities, 2 Nomisma Healthcare, 3 Novo Excipients, 3 Pharmatrans-Sanaq, 3 Pluviaendo, 2 Prachin Chemical, 12 Roquette, 3 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shijiazhuang Huaxu Pharmaceutical, 9 Sigachi Industries, 2 Silverline Chemicals, 1 Ulanqab Kema New Material, 2 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

45 Fillers, Diluents & Binders, 25 Direct Compression, 22 Disintegrants & Superdisintegrants, 20 Coating Systems & Additives, 17 Granulation, 17 Thickeners and Stabilizers, 16 Chewable & Orodispersible Aids, 15 Controlled & Modified Release, 13 Solubilizers, 12 Taste Masking, 12 Lubricants & Glidants, 9 Topical, 9 Co-Processed Excipients, 7 Parenteral, 5 Film Formers & Plasticizers, 3 Emulsifying Agents, 2 API Stability Enhancers, 2 Coloring Agents, 1 Rheology Modifiers

45 Fillers, Diluents & Binders
25 Direct Compression
22 Disintegrants & Superdisintegrants
20 Coating Systems & Additives
17 Granulation
17 Thickeners and Stabilizers
16 Chewable & Orodispersible Aids
15 Controlled & Modified Release
13 Solubilizers
12 Taste Masking
12 Lubricants & Glidants
9 Topical
9 Co-Processed Excipients
7 Parenteral
5 Film Formers & Plasticizers
3 Emulsifying Agents
2 API Stability Enhancers
2 Coloring Agents
1 Rheology Modifiers

DIGITAL CONTENT

58 News #PharmaBuzz

58 News #PharmaBuzz

GLOBAL SALES INFORMATION

1 US Medicaid Prescriptions

1 US Medicaid Prescriptions

MARKET PLACE

2 APIs

2 APIs

PATENTS & EXCLUSIVITIES

23 US Patents, 7 Health Canada Patents

23 US Patents
7 Health Canada Patents

$ API Ref.Price (USD/KG) : 18,560 Xls

Filters

Reset all filters

Filters

FILTER :

filter Company Reset all filters

7 All

01 6Knight Therapeutics Inc

02 1Med-Script Associates Ltd.

filter Patent Reset all filters

7 All

01 12344169

02 12537978

03 12702930

04 12755789

05 12780428

06 12783743

07 12928071

filter Product Reset all filters

7 All

01 7NERATINIB MALEATE

filter Dosage Reset all filters

7 All

01 7TABLET

filter Exp Date Reset all filters

7 All

01 12019-09-22

02 12023-10-15

03 22028-10-16

04 12030-03-24

05 12030-11-02

06 12030-12-06

Product Main Page

01

Knight Therapeutics Inc

Neratinib

Peptide Process CMC

Not Confirmed

Knight Therapeutics Inc

Country

Peptide Process CMC

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2028-10-16

Date Granted : 2016-07-05

Brand Name : NERLYNX

Patent Number : 2702930

Filing Date : 2008-10-16

Strength per Unit : 40 mg

Dosage Form : TABLET

Human Or VET : Human

Route of Administration : ORAL

Patent Expiration Date : 2028-10-16

Date Granted : 2016-07-05

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

02

Med-Script Associates Ltd.

Neratinib

Peptide Process CMC

Not Confirmed

Med-Script Associates Ltd.

Country

Peptide Process CMC

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2019-09-22

Date Granted : 2011-07-19

Brand Name : NERLYNX

Patent Number : 2344169

Filing Date : 1999-09-22

Strength per Unit : 40 mg

Dosage Form : TABLET

Human Or VET : Human

Route of Administration : ORAL

Patent Expiration Date : 2019-09-22

Date Granted : 2011-07-19

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

03

Knight Therapeutics Inc

Neratinib

Peptide Process CMC

Not Confirmed

Knight Therapeutics Inc

Country

Peptide Process CMC

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2028-10-16

Date Granted : 2017-04-25

Brand Name : NERLYNX

Patent Number : 2928071

Filing Date : 2008-10-16

Strength per Unit : 40 mg

Dosage Form : TABLET

Human Or VET : Human

Route of Administration : ORAL

Patent Expiration Date : 2028-10-16

Date Granted : 2017-04-25

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

04

Knight Therapeutics Inc

Neratinib

Peptide Process CMC

Not Confirmed

Knight Therapeutics Inc

Country

Peptide Process CMC

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2030-11-02

Date Granted : 2018-02-13

Brand Name : NERLYNX

Patent Number : 2780428

Filing Date : 2010-11-02

Strength per Unit : 40 mg

Dosage Form : TABLET

Human Or VET : Human

Route of Administration : ORAL

Patent Expiration Date : 2030-11-02

Date Granted : 2018-02-13

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

05

Knight Therapeutics Inc

Neratinib

Peptide Process CMC

Not Confirmed

Knight Therapeutics Inc

Country

Peptide Process CMC

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2023-10-15

Date Granted : 2011-08-02

Brand Name : NERLYNX

Patent Number : 2537978

Filing Date : 2003-10-15

Strength per Unit : 40 mg

Dosage Form : TABLET

Human Or VET : Human

Route of Administration : ORAL

Patent Expiration Date : 2023-10-15

Date Granted : 2011-08-02

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

06

Knight Therapeutics Inc

Neratinib

Peptide Process CMC

Not Confirmed

Knight Therapeutics Inc

Country

Peptide Process CMC

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2030-03-24

Date Granted : 2016-01-19

Brand Name : NERLYNX

Patent Number : 2755789

Filing Date : 2010-03-24

Strength per Unit : 40 mg

Dosage Form : TABLET

Human Or VET : Human

Route of Administration : ORAL

Patent Expiration Date : 2030-03-24

Date Granted : 2016-01-19

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

07

Knight Therapeutics Inc

Neratinib

Peptide Process CMC

Not Confirmed

Knight Therapeutics Inc

Country

Peptide Process CMC

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2030-12-06

Date Granted : 2022-10-04

Brand Name : NERLYNX

Patent Number : 2783743

Filing Date : 2010-12-06

Strength per Unit : 40 mg

Dosage Form : TABLET

Human Or VET : Human

Route of Administration : ORAL

Patent Expiration Date : 2030-12-06

Date Granted : 2022-10-04

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
Ask Us!